Heliyon-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2169271, encodeId=0d3421692e1e7, content=审稿速度:12.0 | 投稿命中率:75.0 偏重的研究方向：综合性期刊 经验分享：11月12日summitted，目前状态没变, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=51, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88fb8437793, createdName=ms7000001652113176, createdTime=Sat Nov 18 08:50:02 CST 2023, time=2023-11-18, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2117858, encodeId=dc8c211e8587c, content=偏重的研究方向：肿瘤;手术 经验分享：25 Feb投稿了一篇seer文章 1 Mar变为了with editor 不知道结果如何希望能中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=33, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=257f6155439, createdName=ms3000000209605964, createdTime=Mon Mar 06 08:28:43 CST 2023, time=2023-03-06, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1207325, encodeId=65be120e325a4, content=审稿速度:6.0 | 投稿命中率:75.0 经验分享：太慢了，搞不懂小修修回为什么1个月了还是under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=31, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/06/05/85b8806981732e640f738d1aebefae1c.jpg, createdBy=e82a2070394, createdName=温和的常常, createdTime=Wed Mar 30 20:35:57 CST 2022, time=2022-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2149743, encodeId=62c92149e439d, content=偏重的研究方向：肿瘤 经验分享：求问大家，decision in process要多久有结果呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fee62100283, createdName=豆豆家的刺猬, createdTime=Tue Jul 25 13:57:07 CST 2023, time=2023-07-25, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2143668, encodeId=3fae214366835, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：代谢产物;细菌素;微生物 经验分享：本来投了food chemistry，大概一个月之后，说不符合杂志的投稿方向（之前明明看到过有类似的文章发表，可能是编辑婉拒的话术吧！），建议转投heliyon，说立刻就能进入under review 阶段（这个纯属忽悠，千万别信，跟重新投稿的流程是一样一样的！），跟导师商量投，确定转投。 2023.05.14 submitted to journal（三天没动静，发邮件给推荐转投的编辑，马上就变了）； 2023.05.18 with editor 2023.06.06 under review （杂志里说2-3周，还真就3周！） 6.8和6.11状态更新了两次，现在仍然是under review，后面有的话再更新状态吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4cb8691503, createdName=ms6000000389987909, createdTime=Mon Jun 19 14:52:35 CST 2023, time=2023-06-19, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2147601, encodeId=3964214e60111, content=记录一下时间线，供兄弟姐妹们参考方向：孟德尔随机化 2023.7.2 submitted to the journal 2023.7.10 with editor 2023.7.11 under review 后续继续追踪, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211209/8c790d426a7f41acb532cdb3a72c5ac7/68f2ff877eb74ef395af90eaacbc8c98.jpg, createdBy=04ed1994321, createdName=Dr.sugar, createdTime=Wed Jul 12 09:08:04 CST 2023, time=2023-07-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2180373, encodeId=e6ed21803e360, content=审稿速度:3.0 经验分享：投了一篇case 23年11月30日接收的，还没让交版面费，这是啥情况呀，谢谢各位大哥, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2cf68540126, createdName=ms6000001563747786, createdTime=Tue Jan 09 21:54:29 CST 2024, time=2024-01-09, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2103810, encodeId=ca332103810cf, content=请问这个是不收稿费的吗，我的中了，并且已经发表了，一直没催交钱是怎么回事儿 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=375a6552492, createdName=ms6000000072243634, createdTime=Thu Dec 01 22:52:29 CST 2022, time=2022-12-01, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2111265, encodeId=e87e21112656c, content=两个review都完成之后变成decision in process四天了啊啊啊这是要被拒了吗T-T 新手好焦虑<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a><a href='/topic/show?id=6b0d10502e60' target=_blank style='color:#2F92EE;'>#Heliyon#</a><a href='/topic/show?id=a1751540260' target=_blank style='color:#2F92EE;'>#review#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=19, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛), TopicDto(id=105027, encryptionId=6b0d10502e60, topicName=Heliyon), TopicDto(id=15402, encryptionId=a1751540260, topicName=review)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28dc8515046, createdName=ms5000001399300995, createdTime=Tue Jan 24 00:39:28 CST 2023, time=2023-01-24, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1233765, encodeId=401f1233e650d, content=2.17提交手稿 2.21到编辑部 2.22一审 3.29大修 4.24提交修稿 5.30到编辑部 6.8 二审 7.4 原则上接受（小修） 7.20接受 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231021/cc493541f9ed457aa70585592ec1b6d1/6695fadc972e4e4184678c99dd4ec738.jpg, createdBy=10905729054, createdName=ms4000001865378676, createdTime=Thu Jul 21 07:30:32 CST 2022, time=2022-07-21, status=1, ipAttribution=)]

2023-11-18 ms7000001652113176 来自安徽省

审稿速度:12.0 | 投稿命中率:75.0
偏重的研究方向：综合性期刊
经验分享：11月12日summitted，目前状态没变

74 51

展开51条回复

[GetPortalCommentsPageByObjectIdResponse(id=2169271, encodeId=0d3421692e1e7, content=审稿速度:12.0 | 投稿命中率:75.0 偏重的研究方向：综合性期刊 经验分享：11月12日summitted，目前状态没变, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=51, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88fb8437793, createdName=ms7000001652113176, createdTime=Sat Nov 18 08:50:02 CST 2023, time=2023-11-18, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2117858, encodeId=dc8c211e8587c, content=偏重的研究方向：肿瘤;手术 经验分享：25 Feb投稿了一篇seer文章 1 Mar变为了with editor 不知道结果如何希望能中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=33, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=257f6155439, createdName=ms3000000209605964, createdTime=Mon Mar 06 08:28:43 CST 2023, time=2023-03-06, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1207325, encodeId=65be120e325a4, content=审稿速度:6.0 | 投稿命中率:75.0 经验分享：太慢了，搞不懂小修修回为什么1个月了还是under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=31, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/06/05/85b8806981732e640f738d1aebefae1c.jpg, createdBy=e82a2070394, createdName=温和的常常, createdTime=Wed Mar 30 20:35:57 CST 2022, time=2022-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2149743, encodeId=62c92149e439d, content=偏重的研究方向：肿瘤 经验分享：求问大家，decision in process要多久有结果呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fee62100283, createdName=豆豆家的刺猬, createdTime=Tue Jul 25 13:57:07 CST 2023, time=2023-07-25, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2143668, encodeId=3fae214366835, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：代谢产物;细菌素;微生物 经验分享：本来投了food chemistry，大概一个月之后，说不符合杂志的投稿方向（之前明明看到过有类似的文章发表，可能是编辑婉拒的话术吧！），建议转投heliyon，说立刻就能进入under review 阶段（这个纯属忽悠，千万别信，跟重新投稿的流程是一样一样的！），跟导师商量投，确定转投。 2023.05.14 submitted to journal（三天没动静，发邮件给推荐转投的编辑，马上就变了）； 2023.05.18 with editor 2023.06.06 under review （杂志里说2-3周，还真就3周！） 6.8和6.11状态更新了两次，现在仍然是under review，后面有的话再更新状态吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4cb8691503, createdName=ms6000000389987909, createdTime=Mon Jun 19 14:52:35 CST 2023, time=2023-06-19, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2147601, encodeId=3964214e60111, content=记录一下时间线，供兄弟姐妹们参考方向：孟德尔随机化 2023.7.2 submitted to the journal 2023.7.10 with editor 2023.7.11 under review 后续继续追踪, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211209/8c790d426a7f41acb532cdb3a72c5ac7/68f2ff877eb74ef395af90eaacbc8c98.jpg, createdBy=04ed1994321, createdName=Dr.sugar, createdTime=Wed Jul 12 09:08:04 CST 2023, time=2023-07-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2180373, encodeId=e6ed21803e360, content=审稿速度:3.0 经验分享：投了一篇case 23年11月30日接收的，还没让交版面费，这是啥情况呀，谢谢各位大哥, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2cf68540126, createdName=ms6000001563747786, createdTime=Tue Jan 09 21:54:29 CST 2024, time=2024-01-09, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2103810, encodeId=ca332103810cf, content=请问这个是不收稿费的吗，我的中了，并且已经发表了，一直没催交钱是怎么回事儿 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=375a6552492, createdName=ms6000000072243634, createdTime=Thu Dec 01 22:52:29 CST 2022, time=2022-12-01, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2111265, encodeId=e87e21112656c, content=两个review都完成之后变成decision in process四天了啊啊啊这是要被拒了吗T-T 新手好焦虑<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a><a href='/topic/show?id=6b0d10502e60' target=_blank style='color:#2F92EE;'>#Heliyon#</a><a href='/topic/show?id=a1751540260' target=_blank style='color:#2F92EE;'>#review#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=19, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛), TopicDto(id=105027, encryptionId=6b0d10502e60, topicName=Heliyon), TopicDto(id=15402, encryptionId=a1751540260, topicName=review)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28dc8515046, createdName=ms5000001399300995, createdTime=Tue Jan 24 00:39:28 CST 2023, time=2023-01-24, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1233765, encodeId=401f1233e650d, content=2.17提交手稿 2.21到编辑部 2.22一审 3.29大修 4.24提交修稿 5.30到编辑部 6.8 二审 7.4 原则上接受（小修） 7.20接受 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231021/cc493541f9ed457aa70585592ec1b6d1/6695fadc972e4e4184678c99dd4ec738.jpg, createdBy=10905729054, createdName=ms4000001865378676, createdTime=Thu Jul 21 07:30:32 CST 2022, time=2022-07-21, status=1, ipAttribution=)]

2023-03-06 ms3000000209605964 来自四川省

偏重的研究方向：肿瘤;手术
经验分享：25 Feb投稿了一篇seer文章 1 Mar变为了with editor 不知道结果如何希望能中

61 33

展开33条回复

[GetPortalCommentsPageByObjectIdResponse(id=2169271, encodeId=0d3421692e1e7, content=审稿速度:12.0 | 投稿命中率:75.0 偏重的研究方向：综合性期刊 经验分享：11月12日summitted，目前状态没变, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=51, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88fb8437793, createdName=ms7000001652113176, createdTime=Sat Nov 18 08:50:02 CST 2023, time=2023-11-18, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2117858, encodeId=dc8c211e8587c, content=偏重的研究方向：肿瘤;手术 经验分享：25 Feb投稿了一篇seer文章 1 Mar变为了with editor 不知道结果如何希望能中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=33, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=257f6155439, createdName=ms3000000209605964, createdTime=Mon Mar 06 08:28:43 CST 2023, time=2023-03-06, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1207325, encodeId=65be120e325a4, content=审稿速度:6.0 | 投稿命中率:75.0 经验分享：太慢了，搞不懂小修修回为什么1个月了还是under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=31, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/06/05/85b8806981732e640f738d1aebefae1c.jpg, createdBy=e82a2070394, createdName=温和的常常, createdTime=Wed Mar 30 20:35:57 CST 2022, time=2022-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2149743, encodeId=62c92149e439d, content=偏重的研究方向：肿瘤 经验分享：求问大家，decision in process要多久有结果呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fee62100283, createdName=豆豆家的刺猬, createdTime=Tue Jul 25 13:57:07 CST 2023, time=2023-07-25, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2143668, encodeId=3fae214366835, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：代谢产物;细菌素;微生物 经验分享：本来投了food chemistry，大概一个月之后，说不符合杂志的投稿方向（之前明明看到过有类似的文章发表，可能是编辑婉拒的话术吧！），建议转投heliyon，说立刻就能进入under review 阶段（这个纯属忽悠，千万别信，跟重新投稿的流程是一样一样的！），跟导师商量投，确定转投。 2023.05.14 submitted to journal（三天没动静，发邮件给推荐转投的编辑，马上就变了）； 2023.05.18 with editor 2023.06.06 under review （杂志里说2-3周，还真就3周！） 6.8和6.11状态更新了两次，现在仍然是under review，后面有的话再更新状态吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4cb8691503, createdName=ms6000000389987909, createdTime=Mon Jun 19 14:52:35 CST 2023, time=2023-06-19, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2147601, encodeId=3964214e60111, content=记录一下时间线，供兄弟姐妹们参考方向：孟德尔随机化 2023.7.2 submitted to the journal 2023.7.10 with editor 2023.7.11 under review 后续继续追踪, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211209/8c790d426a7f41acb532cdb3a72c5ac7/68f2ff877eb74ef395af90eaacbc8c98.jpg, createdBy=04ed1994321, createdName=Dr.sugar, createdTime=Wed Jul 12 09:08:04 CST 2023, time=2023-07-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2180373, encodeId=e6ed21803e360, content=审稿速度:3.0 经验分享：投了一篇case 23年11月30日接收的，还没让交版面费，这是啥情况呀，谢谢各位大哥, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2cf68540126, createdName=ms6000001563747786, createdTime=Tue Jan 09 21:54:29 CST 2024, time=2024-01-09, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2103810, encodeId=ca332103810cf, content=请问这个是不收稿费的吗，我的中了，并且已经发表了，一直没催交钱是怎么回事儿 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=375a6552492, createdName=ms6000000072243634, createdTime=Thu Dec 01 22:52:29 CST 2022, time=2022-12-01, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2111265, encodeId=e87e21112656c, content=两个review都完成之后变成decision in process四天了啊啊啊这是要被拒了吗T-T 新手好焦虑<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a><a href='/topic/show?id=6b0d10502e60' target=_blank style='color:#2F92EE;'>#Heliyon#</a><a href='/topic/show?id=a1751540260' target=_blank style='color:#2F92EE;'>#review#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=19, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛), TopicDto(id=105027, encryptionId=6b0d10502e60, topicName=Heliyon), TopicDto(id=15402, encryptionId=a1751540260, topicName=review)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28dc8515046, createdName=ms5000001399300995, createdTime=Tue Jan 24 00:39:28 CST 2023, time=2023-01-24, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1233765, encodeId=401f1233e650d, content=2.17提交手稿 2.21到编辑部 2.22一审 3.29大修 4.24提交修稿 5.30到编辑部 6.8 二审 7.4 原则上接受（小修） 7.20接受 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231021/cc493541f9ed457aa70585592ec1b6d1/6695fadc972e4e4184678c99dd4ec738.jpg, createdBy=10905729054, createdName=ms4000001865378676, createdTime=Thu Jul 21 07:30:32 CST 2022, time=2022-07-21, status=1, ipAttribution=)]

2022-03-30 温和的常常

审稿速度:6.0 | 投稿命中率:75.0
经验分享：太慢了，搞不懂小修修回为什么1个月了还是under review

55 31

展开31条回复

[GetPortalCommentsPageByObjectIdResponse(id=2169271, encodeId=0d3421692e1e7, content=审稿速度:12.0 | 投稿命中率:75.0 偏重的研究方向：综合性期刊 经验分享：11月12日summitted，目前状态没变, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=51, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88fb8437793, createdName=ms7000001652113176, createdTime=Sat Nov 18 08:50:02 CST 2023, time=2023-11-18, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2117858, encodeId=dc8c211e8587c, content=偏重的研究方向：肿瘤;手术 经验分享：25 Feb投稿了一篇seer文章 1 Mar变为了with editor 不知道结果如何希望能中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=33, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=257f6155439, createdName=ms3000000209605964, createdTime=Mon Mar 06 08:28:43 CST 2023, time=2023-03-06, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1207325, encodeId=65be120e325a4, content=审稿速度:6.0 | 投稿命中率:75.0 经验分享：太慢了，搞不懂小修修回为什么1个月了还是under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=31, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/06/05/85b8806981732e640f738d1aebefae1c.jpg, createdBy=e82a2070394, createdName=温和的常常, createdTime=Wed Mar 30 20:35:57 CST 2022, time=2022-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2149743, encodeId=62c92149e439d, content=偏重的研究方向：肿瘤 经验分享：求问大家，decision in process要多久有结果呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fee62100283, createdName=豆豆家的刺猬, createdTime=Tue Jul 25 13:57:07 CST 2023, time=2023-07-25, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2143668, encodeId=3fae214366835, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：代谢产物;细菌素;微生物 经验分享：本来投了food chemistry，大概一个月之后，说不符合杂志的投稿方向（之前明明看到过有类似的文章发表，可能是编辑婉拒的话术吧！），建议转投heliyon，说立刻就能进入under review 阶段（这个纯属忽悠，千万别信，跟重新投稿的流程是一样一样的！），跟导师商量投，确定转投。 2023.05.14 submitted to journal（三天没动静，发邮件给推荐转投的编辑，马上就变了）； 2023.05.18 with editor 2023.06.06 under review （杂志里说2-3周，还真就3周！） 6.8和6.11状态更新了两次，现在仍然是under review，后面有的话再更新状态吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4cb8691503, createdName=ms6000000389987909, createdTime=Mon Jun 19 14:52:35 CST 2023, time=2023-06-19, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2147601, encodeId=3964214e60111, content=记录一下时间线，供兄弟姐妹们参考方向：孟德尔随机化 2023.7.2 submitted to the journal 2023.7.10 with editor 2023.7.11 under review 后续继续追踪, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211209/8c790d426a7f41acb532cdb3a72c5ac7/68f2ff877eb74ef395af90eaacbc8c98.jpg, createdBy=04ed1994321, createdName=Dr.sugar, createdTime=Wed Jul 12 09:08:04 CST 2023, time=2023-07-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2180373, encodeId=e6ed21803e360, content=审稿速度:3.0 经验分享：投了一篇case 23年11月30日接收的，还没让交版面费，这是啥情况呀，谢谢各位大哥, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2cf68540126, createdName=ms6000001563747786, createdTime=Tue Jan 09 21:54:29 CST 2024, time=2024-01-09, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2103810, encodeId=ca332103810cf, content=请问这个是不收稿费的吗，我的中了，并且已经发表了，一直没催交钱是怎么回事儿 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=375a6552492, createdName=ms6000000072243634, createdTime=Thu Dec 01 22:52:29 CST 2022, time=2022-12-01, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2111265, encodeId=e87e21112656c, content=两个review都完成之后变成decision in process四天了啊啊啊这是要被拒了吗T-T 新手好焦虑<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a><a href='/topic/show?id=6b0d10502e60' target=_blank style='color:#2F92EE;'>#Heliyon#</a><a href='/topic/show?id=a1751540260' target=_blank style='color:#2F92EE;'>#review#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=19, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛), TopicDto(id=105027, encryptionId=6b0d10502e60, topicName=Heliyon), TopicDto(id=15402, encryptionId=a1751540260, topicName=review)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28dc8515046, createdName=ms5000001399300995, createdTime=Tue Jan 24 00:39:28 CST 2023, time=2023-01-24, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1233765, encodeId=401f1233e650d, content=2.17提交手稿 2.21到编辑部 2.22一审 3.29大修 4.24提交修稿 5.30到编辑部 6.8 二审 7.4 原则上接受（小修） 7.20接受 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231021/cc493541f9ed457aa70585592ec1b6d1/6695fadc972e4e4184678c99dd4ec738.jpg, createdBy=10905729054, createdName=ms4000001865378676, createdTime=Thu Jul 21 07:30:32 CST 2022, time=2022-07-21, status=1, ipAttribution=)]

2023-07-25 豆豆家的刺猬来自天津

偏重的研究方向：肿瘤
经验分享：求问大家，decision in process要多久有结果呀

24 21

展开21条回复

[GetPortalCommentsPageByObjectIdResponse(id=2169271, encodeId=0d3421692e1e7, content=审稿速度:12.0 | 投稿命中率:75.0 偏重的研究方向：综合性期刊 经验分享：11月12日summitted，目前状态没变, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=51, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88fb8437793, createdName=ms7000001652113176, createdTime=Sat Nov 18 08:50:02 CST 2023, time=2023-11-18, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2117858, encodeId=dc8c211e8587c, content=偏重的研究方向：肿瘤;手术 经验分享：25 Feb投稿了一篇seer文章 1 Mar变为了with editor 不知道结果如何希望能中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=33, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=257f6155439, createdName=ms3000000209605964, createdTime=Mon Mar 06 08:28:43 CST 2023, time=2023-03-06, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1207325, encodeId=65be120e325a4, content=审稿速度:6.0 | 投稿命中率:75.0 经验分享：太慢了，搞不懂小修修回为什么1个月了还是under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=31, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/06/05/85b8806981732e640f738d1aebefae1c.jpg, createdBy=e82a2070394, createdName=温和的常常, createdTime=Wed Mar 30 20:35:57 CST 2022, time=2022-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2149743, encodeId=62c92149e439d, content=偏重的研究方向：肿瘤 经验分享：求问大家，decision in process要多久有结果呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fee62100283, createdName=豆豆家的刺猬, createdTime=Tue Jul 25 13:57:07 CST 2023, time=2023-07-25, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2143668, encodeId=3fae214366835, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：代谢产物;细菌素;微生物 经验分享：本来投了food chemistry，大概一个月之后，说不符合杂志的投稿方向（之前明明看到过有类似的文章发表，可能是编辑婉拒的话术吧！），建议转投heliyon，说立刻就能进入under review 阶段（这个纯属忽悠，千万别信，跟重新投稿的流程是一样一样的！），跟导师商量投，确定转投。 2023.05.14 submitted to journal（三天没动静，发邮件给推荐转投的编辑，马上就变了）； 2023.05.18 with editor 2023.06.06 under review （杂志里说2-3周，还真就3周！） 6.8和6.11状态更新了两次，现在仍然是under review，后面有的话再更新状态吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4cb8691503, createdName=ms6000000389987909, createdTime=Mon Jun 19 14:52:35 CST 2023, time=2023-06-19, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2147601, encodeId=3964214e60111, content=记录一下时间线，供兄弟姐妹们参考方向：孟德尔随机化 2023.7.2 submitted to the journal 2023.7.10 with editor 2023.7.11 under review 后续继续追踪, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211209/8c790d426a7f41acb532cdb3a72c5ac7/68f2ff877eb74ef395af90eaacbc8c98.jpg, createdBy=04ed1994321, createdName=Dr.sugar, createdTime=Wed Jul 12 09:08:04 CST 2023, time=2023-07-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2180373, encodeId=e6ed21803e360, content=审稿速度:3.0 经验分享：投了一篇case 23年11月30日接收的，还没让交版面费，这是啥情况呀，谢谢各位大哥, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2cf68540126, createdName=ms6000001563747786, createdTime=Tue Jan 09 21:54:29 CST 2024, time=2024-01-09, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2103810, encodeId=ca332103810cf, content=请问这个是不收稿费的吗，我的中了，并且已经发表了，一直没催交钱是怎么回事儿 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=375a6552492, createdName=ms6000000072243634, createdTime=Thu Dec 01 22:52:29 CST 2022, time=2022-12-01, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2111265, encodeId=e87e21112656c, content=两个review都完成之后变成decision in process四天了啊啊啊这是要被拒了吗T-T 新手好焦虑<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a><a href='/topic/show?id=6b0d10502e60' target=_blank style='color:#2F92EE;'>#Heliyon#</a><a href='/topic/show?id=a1751540260' target=_blank style='color:#2F92EE;'>#review#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=19, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛), TopicDto(id=105027, encryptionId=6b0d10502e60, topicName=Heliyon), TopicDto(id=15402, encryptionId=a1751540260, topicName=review)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28dc8515046, createdName=ms5000001399300995, createdTime=Tue Jan 24 00:39:28 CST 2023, time=2023-01-24, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1233765, encodeId=401f1233e650d, content=2.17提交手稿 2.21到编辑部 2.22一审 3.29大修 4.24提交修稿 5.30到编辑部 6.8 二审 7.4 原则上接受（小修） 7.20接受 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231021/cc493541f9ed457aa70585592ec1b6d1/6695fadc972e4e4184678c99dd4ec738.jpg, createdBy=10905729054, createdName=ms4000001865378676, createdTime=Thu Jul 21 07:30:32 CST 2022, time=2022-07-21, status=1, ipAttribution=)]

2023-06-19 ms6000000389987909 来自山东省

审稿速度:6.0 | 投稿命中率:50.0
偏重的研究方向：代谢产物;细菌素;微生物
经验分享：本来投了food chemistry，大概一个月之后，说不符合杂志的投稿方向（之前明明看到过有类似的文章发表，可能是编辑婉拒的话术吧！），建议转投heliyon，说立刻就能进入under review 阶段（这个纯属忽悠，千万别信，跟重新投稿的流程是一样一样的！），跟导师商量投，确定转投。
2023.05.14 submitted to journal（三天没动静，发邮件给推荐转投的编辑，马上就变了）；
2023.05.18 with editor
2023.06.06 under review （杂志里说2-3周，还真就3周！）
6.8和6.11状态更新了两次，现在仍然是under review，后面有的话再更新状态吧

36 20

展开20条回复

[GetPortalCommentsPageByObjectIdResponse(id=2169271, encodeId=0d3421692e1e7, content=审稿速度:12.0 | 投稿命中率:75.0 偏重的研究方向：综合性期刊 经验分享：11月12日summitted，目前状态没变, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=51, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88fb8437793, createdName=ms7000001652113176, createdTime=Sat Nov 18 08:50:02 CST 2023, time=2023-11-18, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2117858, encodeId=dc8c211e8587c, content=偏重的研究方向：肿瘤;手术 经验分享：25 Feb投稿了一篇seer文章 1 Mar变为了with editor 不知道结果如何希望能中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=33, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=257f6155439, createdName=ms3000000209605964, createdTime=Mon Mar 06 08:28:43 CST 2023, time=2023-03-06, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1207325, encodeId=65be120e325a4, content=审稿速度:6.0 | 投稿命中率:75.0 经验分享：太慢了，搞不懂小修修回为什么1个月了还是under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=31, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/06/05/85b8806981732e640f738d1aebefae1c.jpg, createdBy=e82a2070394, createdName=温和的常常, createdTime=Wed Mar 30 20:35:57 CST 2022, time=2022-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2149743, encodeId=62c92149e439d, content=偏重的研究方向：肿瘤 经验分享：求问大家，decision in process要多久有结果呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fee62100283, createdName=豆豆家的刺猬, createdTime=Tue Jul 25 13:57:07 CST 2023, time=2023-07-25, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2143668, encodeId=3fae214366835, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：代谢产物;细菌素;微生物 经验分享：本来投了food chemistry，大概一个月之后，说不符合杂志的投稿方向（之前明明看到过有类似的文章发表，可能是编辑婉拒的话术吧！），建议转投heliyon，说立刻就能进入under review 阶段（这个纯属忽悠，千万别信，跟重新投稿的流程是一样一样的！），跟导师商量投，确定转投。 2023.05.14 submitted to journal（三天没动静，发邮件给推荐转投的编辑，马上就变了）； 2023.05.18 with editor 2023.06.06 under review （杂志里说2-3周，还真就3周！） 6.8和6.11状态更新了两次，现在仍然是under review，后面有的话再更新状态吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4cb8691503, createdName=ms6000000389987909, createdTime=Mon Jun 19 14:52:35 CST 2023, time=2023-06-19, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2147601, encodeId=3964214e60111, content=记录一下时间线，供兄弟姐妹们参考方向：孟德尔随机化 2023.7.2 submitted to the journal 2023.7.10 with editor 2023.7.11 under review 后续继续追踪, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211209/8c790d426a7f41acb532cdb3a72c5ac7/68f2ff877eb74ef395af90eaacbc8c98.jpg, createdBy=04ed1994321, createdName=Dr.sugar, createdTime=Wed Jul 12 09:08:04 CST 2023, time=2023-07-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2180373, encodeId=e6ed21803e360, content=审稿速度:3.0 经验分享：投了一篇case 23年11月30日接收的，还没让交版面费，这是啥情况呀，谢谢各位大哥, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2cf68540126, createdName=ms6000001563747786, createdTime=Tue Jan 09 21:54:29 CST 2024, time=2024-01-09, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2103810, encodeId=ca332103810cf, content=请问这个是不收稿费的吗，我的中了，并且已经发表了，一直没催交钱是怎么回事儿 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=375a6552492, createdName=ms6000000072243634, createdTime=Thu Dec 01 22:52:29 CST 2022, time=2022-12-01, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2111265, encodeId=e87e21112656c, content=两个review都完成之后变成decision in process四天了啊啊啊这是要被拒了吗T-T 新手好焦虑<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a><a href='/topic/show?id=6b0d10502e60' target=_blank style='color:#2F92EE;'>#Heliyon#</a><a href='/topic/show?id=a1751540260' target=_blank style='color:#2F92EE;'>#review#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=19, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛), TopicDto(id=105027, encryptionId=6b0d10502e60, topicName=Heliyon), TopicDto(id=15402, encryptionId=a1751540260, topicName=review)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28dc8515046, createdName=ms5000001399300995, createdTime=Tue Jan 24 00:39:28 CST 2023, time=2023-01-24, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1233765, encodeId=401f1233e650d, content=2.17提交手稿 2.21到编辑部 2.22一审 3.29大修 4.24提交修稿 5.30到编辑部 6.8 二审 7.4 原则上接受（小修） 7.20接受 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231021/cc493541f9ed457aa70585592ec1b6d1/6695fadc972e4e4184678c99dd4ec738.jpg, createdBy=10905729054, createdName=ms4000001865378676, createdTime=Thu Jul 21 07:30:32 CST 2022, time=2022-07-21, status=1, ipAttribution=)]

2023-07-12 Dr.sugar 来自江苏省

记录一下时间线，供兄弟姐妹们参考方向：孟德尔随机化 2023.7.2 submitted to the journal 2023.7.10 with editor 2023.7.11 under review 后续继续追踪

63 19

展开19条回复

[GetPortalCommentsPageByObjectIdResponse(id=2169271, encodeId=0d3421692e1e7, content=审稿速度:12.0 | 投稿命中率:75.0 偏重的研究方向：综合性期刊 经验分享：11月12日summitted，目前状态没变, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=51, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88fb8437793, createdName=ms7000001652113176, createdTime=Sat Nov 18 08:50:02 CST 2023, time=2023-11-18, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2117858, encodeId=dc8c211e8587c, content=偏重的研究方向：肿瘤;手术 经验分享：25 Feb投稿了一篇seer文章 1 Mar变为了with editor 不知道结果如何希望能中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=33, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=257f6155439, createdName=ms3000000209605964, createdTime=Mon Mar 06 08:28:43 CST 2023, time=2023-03-06, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1207325, encodeId=65be120e325a4, content=审稿速度:6.0 | 投稿命中率:75.0 经验分享：太慢了，搞不懂小修修回为什么1个月了还是under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=31, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/06/05/85b8806981732e640f738d1aebefae1c.jpg, createdBy=e82a2070394, createdName=温和的常常, createdTime=Wed Mar 30 20:35:57 CST 2022, time=2022-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2149743, encodeId=62c92149e439d, content=偏重的研究方向：肿瘤 经验分享：求问大家，decision in process要多久有结果呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fee62100283, createdName=豆豆家的刺猬, createdTime=Tue Jul 25 13:57:07 CST 2023, time=2023-07-25, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2143668, encodeId=3fae214366835, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：代谢产物;细菌素;微生物 经验分享：本来投了food chemistry，大概一个月之后，说不符合杂志的投稿方向（之前明明看到过有类似的文章发表，可能是编辑婉拒的话术吧！），建议转投heliyon，说立刻就能进入under review 阶段（这个纯属忽悠，千万别信，跟重新投稿的流程是一样一样的！），跟导师商量投，确定转投。 2023.05.14 submitted to journal（三天没动静，发邮件给推荐转投的编辑，马上就变了）； 2023.05.18 with editor 2023.06.06 under review （杂志里说2-3周，还真就3周！） 6.8和6.11状态更新了两次，现在仍然是under review，后面有的话再更新状态吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4cb8691503, createdName=ms6000000389987909, createdTime=Mon Jun 19 14:52:35 CST 2023, time=2023-06-19, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2147601, encodeId=3964214e60111, content=记录一下时间线，供兄弟姐妹们参考方向：孟德尔随机化 2023.7.2 submitted to the journal 2023.7.10 with editor 2023.7.11 under review 后续继续追踪, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211209/8c790d426a7f41acb532cdb3a72c5ac7/68f2ff877eb74ef395af90eaacbc8c98.jpg, createdBy=04ed1994321, createdName=Dr.sugar, createdTime=Wed Jul 12 09:08:04 CST 2023, time=2023-07-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2180373, encodeId=e6ed21803e360, content=审稿速度:3.0 经验分享：投了一篇case 23年11月30日接收的，还没让交版面费，这是啥情况呀，谢谢各位大哥, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2cf68540126, createdName=ms6000001563747786, createdTime=Tue Jan 09 21:54:29 CST 2024, time=2024-01-09, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2103810, encodeId=ca332103810cf, content=请问这个是不收稿费的吗，我的中了，并且已经发表了，一直没催交钱是怎么回事儿 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=375a6552492, createdName=ms6000000072243634, createdTime=Thu Dec 01 22:52:29 CST 2022, time=2022-12-01, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2111265, encodeId=e87e21112656c, content=两个review都完成之后变成decision in process四天了啊啊啊这是要被拒了吗T-T 新手好焦虑<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a><a href='/topic/show?id=6b0d10502e60' target=_blank style='color:#2F92EE;'>#Heliyon#</a><a href='/topic/show?id=a1751540260' target=_blank style='color:#2F92EE;'>#review#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=19, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛), TopicDto(id=105027, encryptionId=6b0d10502e60, topicName=Heliyon), TopicDto(id=15402, encryptionId=a1751540260, topicName=review)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28dc8515046, createdName=ms5000001399300995, createdTime=Tue Jan 24 00:39:28 CST 2023, time=2023-01-24, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1233765, encodeId=401f1233e650d, content=2.17提交手稿 2.21到编辑部 2.22一审 3.29大修 4.24提交修稿 5.30到编辑部 6.8 二审 7.4 原则上接受（小修） 7.20接受 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231021/cc493541f9ed457aa70585592ec1b6d1/6695fadc972e4e4184678c99dd4ec738.jpg, createdBy=10905729054, createdName=ms4000001865378676, createdTime=Thu Jul 21 07:30:32 CST 2022, time=2022-07-21, status=1, ipAttribution=)]

2024-01-09 ms6000001563747786 来自江西省

审稿速度:3.0
经验分享：投了一篇case 23年11月30日接收的，还没让交版面费，这是啥情况呀，谢谢各位大哥

51 19

展开19条回复

[GetPortalCommentsPageByObjectIdResponse(id=2169271, encodeId=0d3421692e1e7, content=审稿速度:12.0 | 投稿命中率:75.0 偏重的研究方向：综合性期刊 经验分享：11月12日summitted，目前状态没变, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=51, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88fb8437793, createdName=ms7000001652113176, createdTime=Sat Nov 18 08:50:02 CST 2023, time=2023-11-18, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2117858, encodeId=dc8c211e8587c, content=偏重的研究方向：肿瘤;手术 经验分享：25 Feb投稿了一篇seer文章 1 Mar变为了with editor 不知道结果如何希望能中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=33, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=257f6155439, createdName=ms3000000209605964, createdTime=Mon Mar 06 08:28:43 CST 2023, time=2023-03-06, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1207325, encodeId=65be120e325a4, content=审稿速度:6.0 | 投稿命中率:75.0 经验分享：太慢了，搞不懂小修修回为什么1个月了还是under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=31, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/06/05/85b8806981732e640f738d1aebefae1c.jpg, createdBy=e82a2070394, createdName=温和的常常, createdTime=Wed Mar 30 20:35:57 CST 2022, time=2022-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2149743, encodeId=62c92149e439d, content=偏重的研究方向：肿瘤 经验分享：求问大家，decision in process要多久有结果呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fee62100283, createdName=豆豆家的刺猬, createdTime=Tue Jul 25 13:57:07 CST 2023, time=2023-07-25, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2143668, encodeId=3fae214366835, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：代谢产物;细菌素;微生物 经验分享：本来投了food chemistry，大概一个月之后，说不符合杂志的投稿方向（之前明明看到过有类似的文章发表，可能是编辑婉拒的话术吧！），建议转投heliyon，说立刻就能进入under review 阶段（这个纯属忽悠，千万别信，跟重新投稿的流程是一样一样的！），跟导师商量投，确定转投。 2023.05.14 submitted to journal（三天没动静，发邮件给推荐转投的编辑，马上就变了）； 2023.05.18 with editor 2023.06.06 under review （杂志里说2-3周，还真就3周！） 6.8和6.11状态更新了两次，现在仍然是under review，后面有的话再更新状态吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4cb8691503, createdName=ms6000000389987909, createdTime=Mon Jun 19 14:52:35 CST 2023, time=2023-06-19, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2147601, encodeId=3964214e60111, content=记录一下时间线，供兄弟姐妹们参考方向：孟德尔随机化 2023.7.2 submitted to the journal 2023.7.10 with editor 2023.7.11 under review 后续继续追踪, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211209/8c790d426a7f41acb532cdb3a72c5ac7/68f2ff877eb74ef395af90eaacbc8c98.jpg, createdBy=04ed1994321, createdName=Dr.sugar, createdTime=Wed Jul 12 09:08:04 CST 2023, time=2023-07-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2180373, encodeId=e6ed21803e360, content=审稿速度:3.0 经验分享：投了一篇case 23年11月30日接收的，还没让交版面费，这是啥情况呀，谢谢各位大哥, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2cf68540126, createdName=ms6000001563747786, createdTime=Tue Jan 09 21:54:29 CST 2024, time=2024-01-09, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2103810, encodeId=ca332103810cf, content=请问这个是不收稿费的吗，我的中了，并且已经发表了，一直没催交钱是怎么回事儿 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=375a6552492, createdName=ms6000000072243634, createdTime=Thu Dec 01 22:52:29 CST 2022, time=2022-12-01, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2111265, encodeId=e87e21112656c, content=两个review都完成之后变成decision in process四天了啊啊啊这是要被拒了吗T-T 新手好焦虑<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a><a href='/topic/show?id=6b0d10502e60' target=_blank style='color:#2F92EE;'>#Heliyon#</a><a href='/topic/show?id=a1751540260' target=_blank style='color:#2F92EE;'>#review#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=19, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛), TopicDto(id=105027, encryptionId=6b0d10502e60, topicName=Heliyon), TopicDto(id=15402, encryptionId=a1751540260, topicName=review)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28dc8515046, createdName=ms5000001399300995, createdTime=Tue Jan 24 00:39:28 CST 2023, time=2023-01-24, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1233765, encodeId=401f1233e650d, content=2.17提交手稿 2.21到编辑部 2.22一审 3.29大修 4.24提交修稿 5.30到编辑部 6.8 二审 7.4 原则上接受（小修） 7.20接受 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231021/cc493541f9ed457aa70585592ec1b6d1/6695fadc972e4e4184678c99dd4ec738.jpg, createdBy=10905729054, createdName=ms4000001865378676, createdTime=Thu Jul 21 07:30:32 CST 2022, time=2022-07-21, status=1, ipAttribution=)]

2022-12-01 ms6000000072243634 来自河北省

请问这个是不收稿费的吗，我的中了，并且已经发表了，一直没催交钱是怎么回事儿

54 19

展开19条回复

[GetPortalCommentsPageByObjectIdResponse(id=2169271, encodeId=0d3421692e1e7, content=审稿速度:12.0 | 投稿命中率:75.0 偏重的研究方向：综合性期刊 经验分享：11月12日summitted，目前状态没变, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=51, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88fb8437793, createdName=ms7000001652113176, createdTime=Sat Nov 18 08:50:02 CST 2023, time=2023-11-18, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2117858, encodeId=dc8c211e8587c, content=偏重的研究方向：肿瘤;手术 经验分享：25 Feb投稿了一篇seer文章 1 Mar变为了with editor 不知道结果如何希望能中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=33, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=257f6155439, createdName=ms3000000209605964, createdTime=Mon Mar 06 08:28:43 CST 2023, time=2023-03-06, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1207325, encodeId=65be120e325a4, content=审稿速度:6.0 | 投稿命中率:75.0 经验分享：太慢了，搞不懂小修修回为什么1个月了还是under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=31, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/06/05/85b8806981732e640f738d1aebefae1c.jpg, createdBy=e82a2070394, createdName=温和的常常, createdTime=Wed Mar 30 20:35:57 CST 2022, time=2022-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2149743, encodeId=62c92149e439d, content=偏重的研究方向：肿瘤 经验分享：求问大家，decision in process要多久有结果呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fee62100283, createdName=豆豆家的刺猬, createdTime=Tue Jul 25 13:57:07 CST 2023, time=2023-07-25, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2143668, encodeId=3fae214366835, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：代谢产物;细菌素;微生物 经验分享：本来投了food chemistry，大概一个月之后，说不符合杂志的投稿方向（之前明明看到过有类似的文章发表，可能是编辑婉拒的话术吧！），建议转投heliyon，说立刻就能进入under review 阶段（这个纯属忽悠，千万别信，跟重新投稿的流程是一样一样的！），跟导师商量投，确定转投。 2023.05.14 submitted to journal（三天没动静，发邮件给推荐转投的编辑，马上就变了）； 2023.05.18 with editor 2023.06.06 under review （杂志里说2-3周，还真就3周！） 6.8和6.11状态更新了两次，现在仍然是under review，后面有的话再更新状态吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4cb8691503, createdName=ms6000000389987909, createdTime=Mon Jun 19 14:52:35 CST 2023, time=2023-06-19, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2147601, encodeId=3964214e60111, content=记录一下时间线，供兄弟姐妹们参考方向：孟德尔随机化 2023.7.2 submitted to the journal 2023.7.10 with editor 2023.7.11 under review 后续继续追踪, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211209/8c790d426a7f41acb532cdb3a72c5ac7/68f2ff877eb74ef395af90eaacbc8c98.jpg, createdBy=04ed1994321, createdName=Dr.sugar, createdTime=Wed Jul 12 09:08:04 CST 2023, time=2023-07-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2180373, encodeId=e6ed21803e360, content=审稿速度:3.0 经验分享：投了一篇case 23年11月30日接收的，还没让交版面费，这是啥情况呀，谢谢各位大哥, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2cf68540126, createdName=ms6000001563747786, createdTime=Tue Jan 09 21:54:29 CST 2024, time=2024-01-09, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2103810, encodeId=ca332103810cf, content=请问这个是不收稿费的吗，我的中了，并且已经发表了，一直没催交钱是怎么回事儿 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=375a6552492, createdName=ms6000000072243634, createdTime=Thu Dec 01 22:52:29 CST 2022, time=2022-12-01, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2111265, encodeId=e87e21112656c, content=两个review都完成之后变成decision in process四天了啊啊啊这是要被拒了吗T-T 新手好焦虑<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a><a href='/topic/show?id=6b0d10502e60' target=_blank style='color:#2F92EE;'>#Heliyon#</a><a href='/topic/show?id=a1751540260' target=_blank style='color:#2F92EE;'>#review#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=19, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛), TopicDto(id=105027, encryptionId=6b0d10502e60, topicName=Heliyon), TopicDto(id=15402, encryptionId=a1751540260, topicName=review)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28dc8515046, createdName=ms5000001399300995, createdTime=Tue Jan 24 00:39:28 CST 2023, time=2023-01-24, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1233765, encodeId=401f1233e650d, content=2.17提交手稿 2.21到编辑部 2.22一审 3.29大修 4.24提交修稿 5.30到编辑部 6.8 二审 7.4 原则上接受（小修） 7.20接受 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231021/cc493541f9ed457aa70585592ec1b6d1/6695fadc972e4e4184678c99dd4ec738.jpg, createdBy=10905729054, createdName=ms4000001865378676, createdTime=Thu Jul 21 07:30:32 CST 2022, time=2022-07-21, status=1, ipAttribution=)]

2023-01-24 ms5000001399300995 来自福建省

两个review都完成之后变成decision in process四天了啊啊啊这是要被拒了吗T-T 新手好焦虑#期刊论坛##Heliyon##review#

74 19

展开19条回复

[GetPortalCommentsPageByObjectIdResponse(id=2169271, encodeId=0d3421692e1e7, content=审稿速度:12.0 | 投稿命中率:75.0 偏重的研究方向：综合性期刊 经验分享：11月12日summitted，目前状态没变, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=51, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88fb8437793, createdName=ms7000001652113176, createdTime=Sat Nov 18 08:50:02 CST 2023, time=2023-11-18, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2117858, encodeId=dc8c211e8587c, content=偏重的研究方向：肿瘤;手术 经验分享：25 Feb投稿了一篇seer文章 1 Mar变为了with editor 不知道结果如何希望能中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=33, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=257f6155439, createdName=ms3000000209605964, createdTime=Mon Mar 06 08:28:43 CST 2023, time=2023-03-06, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1207325, encodeId=65be120e325a4, content=审稿速度:6.0 | 投稿命中率:75.0 经验分享：太慢了，搞不懂小修修回为什么1个月了还是under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=31, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/06/05/85b8806981732e640f738d1aebefae1c.jpg, createdBy=e82a2070394, createdName=温和的常常, createdTime=Wed Mar 30 20:35:57 CST 2022, time=2022-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2149743, encodeId=62c92149e439d, content=偏重的研究方向：肿瘤 经验分享：求问大家，decision in process要多久有结果呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fee62100283, createdName=豆豆家的刺猬, createdTime=Tue Jul 25 13:57:07 CST 2023, time=2023-07-25, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2143668, encodeId=3fae214366835, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：代谢产物;细菌素;微生物 经验分享：本来投了food chemistry，大概一个月之后，说不符合杂志的投稿方向（之前明明看到过有类似的文章发表，可能是编辑婉拒的话术吧！），建议转投heliyon，说立刻就能进入under review 阶段（这个纯属忽悠，千万别信，跟重新投稿的流程是一样一样的！），跟导师商量投，确定转投。 2023.05.14 submitted to journal（三天没动静，发邮件给推荐转投的编辑，马上就变了）； 2023.05.18 with editor 2023.06.06 under review （杂志里说2-3周，还真就3周！） 6.8和6.11状态更新了两次，现在仍然是under review，后面有的话再更新状态吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4cb8691503, createdName=ms6000000389987909, createdTime=Mon Jun 19 14:52:35 CST 2023, time=2023-06-19, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2147601, encodeId=3964214e60111, content=记录一下时间线，供兄弟姐妹们参考方向：孟德尔随机化 2023.7.2 submitted to the journal 2023.7.10 with editor 2023.7.11 under review 后续继续追踪, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211209/8c790d426a7f41acb532cdb3a72c5ac7/68f2ff877eb74ef395af90eaacbc8c98.jpg, createdBy=04ed1994321, createdName=Dr.sugar, createdTime=Wed Jul 12 09:08:04 CST 2023, time=2023-07-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2180373, encodeId=e6ed21803e360, content=审稿速度:3.0 经验分享：投了一篇case 23年11月30日接收的，还没让交版面费，这是啥情况呀，谢谢各位大哥, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2cf68540126, createdName=ms6000001563747786, createdTime=Tue Jan 09 21:54:29 CST 2024, time=2024-01-09, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2103810, encodeId=ca332103810cf, content=请问这个是不收稿费的吗，我的中了，并且已经发表了，一直没催交钱是怎么回事儿 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=375a6552492, createdName=ms6000000072243634, createdTime=Thu Dec 01 22:52:29 CST 2022, time=2022-12-01, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2111265, encodeId=e87e21112656c, content=两个review都完成之后变成decision in process四天了啊啊啊这是要被拒了吗T-T 新手好焦虑<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a><a href='/topic/show?id=6b0d10502e60' target=_blank style='color:#2F92EE;'>#Heliyon#</a><a href='/topic/show?id=a1751540260' target=_blank style='color:#2F92EE;'>#review#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=19, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛), TopicDto(id=105027, encryptionId=6b0d10502e60, topicName=Heliyon), TopicDto(id=15402, encryptionId=a1751540260, topicName=review)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28dc8515046, createdName=ms5000001399300995, createdTime=Tue Jan 24 00:39:28 CST 2023, time=2023-01-24, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1233765, encodeId=401f1233e650d, content=2.17提交手稿 2.21到编辑部 2.22一审 3.29大修 4.24提交修稿 5.30到编辑部 6.8 二审 7.4 原则上接受（小修） 7.20接受 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231021/cc493541f9ed457aa70585592ec1b6d1/6695fadc972e4e4184678c99dd4ec738.jpg, createdBy=10905729054, createdName=ms4000001865378676, createdTime=Thu Jul 21 07:30:32 CST 2022, time=2022-07-21, status=1, ipAttribution=)]

2022-07-21 ms4000001865378676

2.17提交手稿 2.21到编辑部 2.22一审 3.29大修 4.24提交修稿 5.30到编辑部 6.8 二审 7.4 原则上接受（小修） 7.20接受

69 18

展开18条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务